Xiaochun Yang

1.4k total citations
48 papers, 1.1k citations indexed

About

Xiaochun Yang is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiaochun Yang has authored 48 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 15 papers in Oncology and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiaochun Yang's work include Cancer therapeutics and mechanisms (7 papers), Lung Cancer Treatments and Mutations (7 papers) and PI3K/AKT/mTOR signaling in cancer (6 papers). Xiaochun Yang is often cited by papers focused on Cancer therapeutics and mechanisms (7 papers), Lung Cancer Treatments and Mutations (7 papers) and PI3K/AKT/mTOR signaling in cancer (6 papers). Xiaochun Yang collaborates with scholars based in China, Indonesia and United States. Xiaochun Yang's co-authors include Qiaojun He, Bo Yang, Peihua Luo, Hao Yan, Zhifei Xu, Yongzhou Hu, Meidan Ying, Jian Chen, Ji Cao and Honghai Wu and has published in prestigious journals such as Nature Communications, Biochemical Pharmacology and Cardiovascular Research.

In The Last Decade

Xiaochun Yang

45 papers receiving 1.1k citations

Peers

Xiaochun Yang

ONCOL

IMMUN

PRM

Joanna M. Poczobutt United States

Peihua Luo China

Santosh Karnewar India

M. Lakshmi Kuppusamy United States

Amal Kamal Abdel‐Aziz Egypt

Yi Ban United States

Zhinong Jiang China

Antonella Cusimano Italy

Sébastien Sauvage Belgium

Changzheng Li China

Joanna M. Poczobutt United States

Xiaochun Yang

491 ×1.0

332 ×1.1

ONCOL

425 ×2.1

IMMUN

104 ×0.6

156 ×1.0

PRM

Citations per year, relative to Xiaochun Yang Xiaochun Yang (= 1×) peers Joanna M. Poczobutt

Countries citing papers authored by Xiaochun Yang

Since Specialization

Citations

This map shows the geographic impact of Xiaochun Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaochun Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaochun Yang more than expected).

Fields of papers citing papers by Xiaochun Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaochun Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaochun Yang. The network helps show where Xiaochun Yang may publish in the future.

Co-authorship network of co-authors of Xiaochun Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaochun Yang. A scholar is included among the top collaborators of Xiaochun Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaochun Yang. Xiaochun Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yan, Hao, Mu Yuan, Zhifei Xu, et al.. (2025). Disturbing Cholesterol/Sphingolipid Metabolism by Squalene Epoxidase Arises Crizotinib Hepatotoxicity. Advanced Science. 12(14). e2414923–e2414923. 2 indexed citations

Yang, Wendong, Jiabin Lu, Peihua Luo, et al.. (2025). An exhaustive examination of the research progress in identifying potential JAK inhibitors from natural products: a comprehensive overview. Chinese Medicine. 20(1). 130–130.

Yang, Xiaochun & Lixiong Xu. (2024). Optimal Distribution Grid Scheduling Strategy in the Context of Insufficient Power Supply During Extreme Weather Events. 747–752.

Liu, Ning, Taicheng Zhou, Jian Chen, et al.. (2024). Schisandrin C prevents regorafenib-induced cardiotoxicity by recovering EPHA2 expression in cardiomyocytes. Toxicological Sciences. 202(2). 220–235. 1 indexed citations

Li, Jinjin, Xueqin Chen, Yunfang Zhou, et al.. (2024). Rutin attenuates ensartinib-induced hepatotoxicity by non-transcriptional regulation of TXNIP. Cell Biology and Toxicology. 40(1). 38–38. 2 indexed citations

Xu, Zhifei, Bo Yang, Qiaojun He, et al.. (2023). An update on Alectinib: a first line treatment for ALK-positive advanced lung cancer. Expert Opinion on Pharmacotherapy. 24(12). 1361–1373. 1 indexed citations

Yang, Xiaochun, Zhifei Xu, Bo Yang, et al.. (2023). The participation of non-canonical autophagic proteins in the autophagy process and their potential as therapeutic targets. Expert Opinion on Therapeutic Targets. 27(1). 71–86. 1 indexed citations

Yan, Hao, Jinjin Li, Xueqin Chen, et al.. (2023). Regorafenib inhibits EphA2 phosphorylation and leads to liver damage via the ERK/MDM2/p53 axis. Nature Communications. 14(1). 2756–2756. 31 indexed citations

Yan, Hao, Ying Zhang, Jiajia Chen, et al.. (2023). Chloroquine Intervenes Nephrotoxicity of Nilotinib through Deubiquitinase USP13‐Mediated Stabilization of Bcl‐XL. Advanced Science. 10(26). e2302002–e2302002. 9 indexed citations

10.

Yan, Hao, Xiaochun Yang, Bo Yang, et al.. (2022). Dasatinib causes keratinocyte apoptosis via inhibiting high mobility group Box 1-mediated mitophagy. Toxicology Letters. 373. 22–32. 5 indexed citations

11.

Chen, Jian, Hao Yan, Qiaojun He, et al.. (2020). <p>Research Status and Outlook of PD-1/PD-L1 Inhibitors for Cancer Therapy</p>. Drug Design Development and Therapy. Volume 14. 3625–3649. 139 indexed citations

12.

Jiang, Liyu, Ping Li, Hao Yan, et al.. (2020). Cardiovascular toxicity induced by anti-VEGF/VEGFR agents: a special focus on definitions, diagnoses, mechanisms and management. Expert Opinion on Drug Metabolism & Toxicology. 16(9). 823–835. 16 indexed citations

13.

Li, Guanqun, Liyu Jiang, Xiaochen Zhang, et al.. (2020). Crosstalk between alveolar macrophages and alveolar epithelial cells/fibroblasts contributes to the pulmonary toxicity of gefitinib. Toxicology Letters. 338. 1–9. 6 indexed citations

14.

Zhang, Xiaochen, Xueqin Chen, Ziye Zhou, et al.. (2019). Keratinocytes apoptosis contributes to crizotinib induced-erythroderma. Toxicology Letters. 319. 102–110. 7 indexed citations

15.

Luo, Peihua, Yi Zhu, Min Chen, et al.. (2018). HMGB1 contributes to adriamycin-induced cardiotoxicity via up-regulating autophagy. Toxicology Letters. 292. 115–122. 47 indexed citations

16.

Zhou, Qian, Miao Xian, Senfeng Xiang, et al.. (2017). All-Trans Retinoic Acid Prevents Osteosarcoma Metastasis by Inhibiting M2 Polarization of Tumor-Associated Macrophages. Cancer Immunology Research. 5(7). 547–559. 121 indexed citations

17.

Lou, Siyue, Like Zhong, Xiaochun Yang, et al.. (2012). Efficacy of all-trans retinoid acid in preventing nickel induced cardiotoxicity in myocardial cells of rats. Food and Chemical Toxicology. 51. 251–258. 13 indexed citations

18.

Yang, Xiaochun, Chunqi Hu, Tao Liu, et al.. (2010). Synthesis and biological evaluation of new 4β-anilino-4′-O-demethyl-4-desoxypodophyllotoxin derivatives as potential antitumor agents. European Journal of Medicinal Chemistry. 46(1). 285–296. 18 indexed citations

19.

Zhang, Chong, Hong Zhu, Xiaochun Yang, et al.. (2009). P53 and p38 MAPK pathways are involved in MONCPT-induced cell cycle G2/M arrest in human non-small cell lung cancer A549. Journal of Cancer Research and Clinical Oncology. 136(3). 437–445. 22 indexed citations

20.

Du, Wenting, Lan Hong, Tong-wei Yao, et al.. (2007). Synthesis and evaluation of water-soluble docetaxel prodrugs-docetaxel esters of malic acid. Bioorganic & Medicinal Chemistry. 15(18). 6323–6330. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact